ESI-09

CAS : 263707-16-0

Ref. 3D-NKA70716

Informations sur le produit

• Nom: ESI-09
• CAS: 263707-16-0

Description

ESI-09 is a novel drug candidate that has been shown to have synergistic effects with chemotherapeutic agents in the treatment of cancer. It is a potential drug target for cancer, and its anticancer activity may be due to its ability to reduce oxidative stress by activating antioxidant enzymes. ESI-09 has antioxidative properties and decreases the mitochondrial membrane potential, which leads to increased ATP levels. ESI-09 also has the ability to cause cell death by inhibiting aerobic glycolysis, which may be due to its inhibitory effects on the polymerase chain reaction (PCR).

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 330.77 g/mol
• Formule: C₁₆H₁₅ClN₄O₂
• Degré de pureté: Min. 95%